Dr. Adam McLain Kase, MD

Dr. Kase practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Kase's NPI, 1114351574, was assigned on August 21, 2013. Dr. Kase graduated from Mercer University School of Medicine in 2016. Dr. Kase holds Florida license ME133192.

Dr. Kase's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Kase's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kase practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kase's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kase is board certified in hematology by the American Board of Internal Medicine. Dr. Kase is licensed in Florida.

Dmand AI lists chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Kase treats.

CMS data shows 94,917 Medicare services from Dr. Kase across 57 procedure codes in 2024, for 1,061 Medicare patients. Medicare paid $1,512,706 for them. Every service was in an office.

CMS counts 1,061 Medicare patients who saw Dr. Kase in 2024. The largest group is 65 to 74, with 520 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kase's median patient age at 65, with 35% women.

In 2024, Dr. Kase wrote 786 Medicare Part D claims for 151 patients. 71% of them were for generic drugs. CMS names the drug for 680 of them, across 12 drugs with 11 or more claims each, at $1,798,281 in total drug cost. In 2023, CMS named 251 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Kase for performance year 2024, reported as part of a group. Dr. Kase accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kase as offering telehealth.

Dmand AI links 17 papers to Dr. Kase, published from 2018 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Prostatic Neoplasms, Castration-Resistant, Antineoplastic Combined Chemotherapy Protocols and Dipeptides. Dr. Kase has published most often in Cancers (Basel). Dr. Kase's most frequent co-authors are Winston Tan, MD, Jacob Jennings Orme, MD, PhD and Daniel Self Childs, MD.

CMS Open Payments shows 40 general payments to Dr. Kase from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Seagen Inc. paid the most, $663.

Dmand AI lists 4 awards for Dr. Kase, most recently Conquer Cancer Merit Award in 2022. Dr. Kase serves on Mayo Clinic Alix School of Medicine Campus Admissions Subcommittee.

Dr. Kase graduated from Mercer University School of Medicine in 2016. Dr. Kase is a member of AACR, ACP and ASCO.

Dr. Kase is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.